The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.
from WebMD Health https://ift.tt/3l2Pid2
Friday, 1 October 2021
Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID
from WebMD Health https://ift.tt/3l2Pid2
0 comments:
Post a Comment